Webinar: Lessons Learned from Inspections and Audits During COVID-19
April 26, 2022
While the efforts and procedures of many regulatory bodies ground to a halt during the COVID-19 pandemic, the US Food and Drug Administration (FDA) pressed on with inspection. However, the agency’s tactics shifted as it adopted remote tools to connect with pharma and digital health companies before deciding on performing in-person audits. In an upcoming MasterControl webinar on May 4th, Senior Project Managers Nate Henriod and Peter Harris explain these changes and the new tools the FDA has adopted.
According to Master Control, The key takeaways of the webinar are, “
- The remote tools that the FDA uses to interact with pharmaceutical and medical device companies.
- Why audit management systems and quality software help with inspections.
- How the same tools that help with inspections help with quality assurance audits.”
To read more and register for the free webinar, click here.
(Source: MasterControl, April 26th, 2022)